The company
Sera Prognostics, Inc.
SERA · Nasdaq
SERA stood above a rising 150-day average in 7 of the last 52 weekly readings, and has been out of that trend for the last 38 weeks. It is 0.8% above that average now. Diagnostics & Labs: 50% of its 44 stocks in an uptrend (+2 points in four weeks); Health Care: 26% (−10 points in four weeks).
Statistics
- Rotation
- Above a falling average
- Weeks in an uptrend
- out for 38
- Industry in uptrend
- 50% +2 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $923K
- Officials’ trades on record
- 0
- Institutions holding
- 46 (-8)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 7 of 52 weeks.
Diagnostics & Labs: About half its stocks are in an uptrend and the share has held steady. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Tiffany Eul Davis InglisChief Medical Officer | sold | 8,024at $2.03 | 12 Oct 2026filed 13 Oct 2026 |
| Benjamin JacksonGeneral Counsel | sold | 2,190at $2.00 | 10 Sep 2026filed 11 Sep 2026 |
| Zhenya LindgardtChief Executive Officer | sold | 7,022at $2.00 | 10 Sep 2026filed 11 Sep 2026 |
| Dyaarl Lee Anderson, Jr.Chief Commercial Officer | sold | 1,800at $2.00 | 10 Sep 2026filed 11 Sep 2026 |
| Tiffany Eul Davis InglisChief Medical Officer | sold | 486at $2.00 | 10 Sep 2026filed 11 Sep 2026 |
| Zhenya LindgardtChief Executive Officer | sold | 20,139at $2.00 | 8 Sep 2026filed 9 Sep 2026 |
| Benjamin JacksonGeneral Counsel | sold | 2,179at $2.01 | 11 Jun 2026filed 15 Jun 2026 |
| Zhenya LindgardtChief Executive Officer | sold | 6,990at $2.01 | 11 Jun 2026filed 15 Jun 2026 |
| Austin AertsChief Financial Officer | sold | 2,037at $2.01 | 11 Jun 2026filed 15 Jun 2026 |
| Dyaarl Lee Anderson, Jr.Chief Commercial Officer | sold | 4,739at $2.01 | 11 Jun 2026filed 15 Jun 2026 |
| Tiffany Eul Davis InglisChief Medical Officer | sold | 362at $2.01 | 11 Jun 2026filed 15 Jun 2026 |
| Zhenya LindgardtChief Executive Officer | sold | 20,755at $2.08 | 9 Jun 2026filed 10 Jun 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BAKER BROS. ADVISORS LPunchanged · filed 14 Aug 2026 | 5,498,170$10.0M | 00.0% |
| Whetstone Capital Advisors, LLCunchanged · filed 14 Aug 2026 | 3,306,889$6.0M | 00.0% |
| Aberdeen Group plcadded · filed 31 Jul 2026 | 2,753,525$5.0M | +202,750+7.9% |
| Vivo Capital, LLCunchanged · filed 14 Aug 2026 | 1,650,440$3.0M | 00.0% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 1,297,792$2.4M | +93,677+7.8% |
| CAPTRUST FINANCIAL ADVISORSreduced · filed 13 Aug 2026 | 535,755$975K | -1,006−0.2% |
| GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026 | 348,967$635K | -14,650−4.0% |
| BlackRock, Inc.added · filed 7 Aug 2026 | 221,369$403K | +25,264+12.9% |
| AWM Investment Company, Inc.unchanged · filed 14 Aug 2026 | 207,382$377K | 00.0% |
| VANGUARD FIDUCIARY TRUST COadded · filed 13 Aug 2026 | 170,908$311K | +1,247+0.7% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.